Saikosaponin-d enhances the anticancer potency of TNF- α via overcoming its undesirable response of activating NF-kappa B signalling in cancer cells

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Wong, Vincent Kam Wai ^a   Zhang, Molly Miao ^b   Zhou, Hua ^a   Lam, Kelly Yin Ching ^b   Chan, Po Ling ^b   Law, Carmen Ka Man ^b   Yue, Patrick Ying Kit ^b   Liu, Liang ^a  

^a MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SAIKOSAPONIN D; SAPONIN; TRITERPENE; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; BUPLEURUM; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; CELL DEATH; CELL LINE; CELL STRAIN HEPG2; DRUG POTENCY; GENE EXPRESSION; HUMAN; HUMAN CELL; MEDICINAL PLANT; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84876545441     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/745295     Document Type: Article

References (65)

1. Drutskaya M. S., Efimov G. A., Kruglov A. A., Kuprash D. V., Nedospasov S. A., Tumor necrosis factor, lymphotoxin and cancer. IUBMB Life 2010 62 4 283 289 2-s2.0-77951118237 10.1002/iub.309
2. Hsu H., Xiong J., Goeddel D. V., The TNF receptor 1-associated protein TRADD signals cell death and NF- B activation. Cell 1995 81 4 495 504 2-s2.0-0029007855
3. Hsu H., Shu H. B., Pan M. G., Goeddel D. V., TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996 84 2 299 308 2-s2.0-0030032106 10.1016/S0092-8674(00)80984-8 (Pubitemid 26042835)
4. Morgan M. J., Liu Z. G., Reactive oxygen species in TNF α -induced signaling and cell death. Molecules and Cells 2010 30 1 1 12 2-s2.0-77955035878 10.1007/s10059-010-0105-0
5. Pennica D., Nedwin G. E., Hayflick J. S., Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984 312 5996 724 729 2-s2.0-0021681058 (Pubitemid 15195918)
6. Brouckaert P. G., Leroux-Roels G. G., Guisez Y., Tavernier J., Fiers W., In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN- γ on a syngeneic murine melanoma. International Journal of Cancer 1986 38 5 763 769 2-s2.0-0023009932 (Pubitemid 17189137)
7. Balkwill F. R., Lee A., Aldam G., Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. Cancer Research 1986 46 8 3990 3993 2-s2.0-0022470478 (Pubitemid 16075896)
8. Deroose J. P., Eggermont A. M., van Geel A. N., Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas. Journal of Clinical Oncology 2011 29 30 4036 4044
9. Deroose J. P., Eggermont A. M., van Geel A. N., de Wilt J. H., Burger J. W., Verhoef C., 20 years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose matters. Annals of Surgical Oncology 2012 19 2 627 635
10. Grünhagen D. J., de Wilt J. H. W., Van Geel A. N., Verhoef C., Eggermont A. M. M., Isolated limb perfusion with TNF- α and melphalan in locally advanced soft tissue sarcomas of the extremities. Recent Results in Cancer Research 2009 179 257 270 2-s2.0-62249181618 10.1007/978-3-540-77960-5-16
11. Lucas R., Kresse M., Latta M., Wendel A., Tumor necrosis factor: How to make a killer molecule tumor-specific? Current Cancer Drug Targets 2005 5 6 381 392 2-s2.0-23844470601 10.2174/1568009054863627 (Pubitemid 41176177)
12. Aggarwal B. B., Nuclear factor- B: the enemy within. Cancer Cell 2004 6 3 203 208 2-s2.0-4544342570 10.1016/j.ccr.2004.09.003 (Pubitemid 39222032)
13. Aggarwal B. B., Gupta S. C., Kim J. H., Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood 2012 119 3 651 665
14. Balkwill F., Tumour necrosis factor and cancer. Nature Reviews Cancer 2009 9 5 361 371 2-s2.0-67349162130 10.1038/nrc2628
15. Aggarwal B. B., Shishodia S., Sandur S. K., Pandey M. K., Sethi G., Inflammation and cancer: how hot is the link? Biochemical Pharmacology 2006 72 11 1605 1621 2-s2.0-33750497844 10.1016/j.bcp.2006.06.029 (Pubitemid 44666739)
16. Nakanishi C., Toi M., Nuclear factor- B inhibitors as sensitizers to anticancer drugs. Nature Reviews Cancer 2005 5 4 297 309 2-s2.0-16844366650 10.1038/nrc1588 (Pubitemid 40488635)
17. Karin M., Nuclear factor- B in cancer development and progression. Nature 2006 441 7092 431 436 2-s2.0-33745298519 10.1038/nature04870 (Pubitemid 44050137)
18. Tundis R., Bonesi M., Deguin B., Loizzo M. R., Menichini F., Conforti F., Tillequin F., Menichini F., Cytotoxic activity and inhibitory effect on nitric oxide production of triterpene saponins from the roots of Physospermum verticillatum (Waldst & Kit) (Apiaceae). Bioorganic and Medicinal Chemistry 2009 17 13 4542 4547 2-s2.0-66449117042 10.1016/j.bmc.2009.05.006
19. Wong V. K. W., Zhou H., Cheung S. S. F., Li T., Liu L., Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation. Journal of Cellular Biochemistry 2009 107 2 303 315 2-s2.0-66149145372 10.1002/jcb.22126
20. Yue P. Y. K., Leung E. P. Y., Mak N. K., Wong R. N. S., A simplified method for quantifying cell migration/wound healing in 96-well plates. Journal of Biomolecular Screening 2010 15 4 427 433 2-s2.0-77952326078 10.1177/1087057110361772
21. Moon D. O., Kim M. O., Kang S. H., Choi Y. H., Kim G. Y., Sulforaphane suppresses TNF- α -mediated activation of NF- B and induces apoptosis through activation of reactive oxygen species-dependent caspase-3. Cancer Letters 2009 274 1 132 142 2-s2.0-57749088548 10.1016/j.canlet.2008.09.013
22. Lee K., Lee M. H., Kang Y. W., Rhee K. J., Kim T. U., Kim Y. S., Parkin induces apoptotic cell death in TNF-alpha-treated cervical cancer cells. BMB Reports 2012 45 9 526 531
23. Wang W., Gallant J. N., Katz S. I., Dolloff N. G., Smith C. D., Abdulghani J., Allen J. E., Dicker D. T., Hong B., Navaraj A., El-Deiry W. S., Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents. Cancer Biology and Therapy 2011 12 3 229 238 2-s2.0-79961232741 10.4161/cbt.12.3.17033
24. De Proost I., Pintelon I., Brouns I., Kroese A. B. A., Riccardi D., Kemp P. J., Timmermans J. P., Adriaensen D., Functional live cell imaging of the pulmonary neuroepithelial body microenvironment. American Journal of Respiratory Cell and Molecular Biology 2008 39 2 180 189 2-s2.0-48649094116 10.1165/rcmb.2008-0011OC
25. Zhong H., Voll R. E., Ghosh S., Phosphorylation of NF- B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Molecular Cell 1998 1 5 661 671 2-s2.0-0032039076 (Pubitemid 128379244)
26. Malnou C. E., Salem T., Brockly F., Wodrich H., Piechaczyk M., Jariel-Encontre I., Heterodimerization with Jun family members regulates c-Fos nucleocytoplasmic traffic. The Journal of Biological Chemistry 2007 282 42 31046 31059 2-s2.0-35649000375 10.1074/jbc.M702833200 (Pubitemid 350035170)
27. Yamamoto Y., Gaynor R. B., Therapeutic potential of inhibition of the NF- B pathway in the treatment of inflammation and cancer. The Journal of Clinical Investigation 2001 107 2 135 142 2-s2.0-0035139792 (Pubitemid 32096826)
28. Kunnumakkara A. B., Anand P., Aggarwal B. B., Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Letters 2008 269 2 199 225 2-s2.0-51349137454 10.1016/j.canlet.2008.03.009
29. Shishodia S., Aggarwal B. B., Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I B kinase activation and NF- B-regulated gene expression. Oncogene 2006 25 10 1463 1473 2-s2.0-33644840279 10.1038/sj.onc.1209194 (Pubitemid 43361932)
30. Lopes F. C. M., Rocha A., Pirraco A., Regasini L. O., Silva D. H. S., Bolzani V. S., Azevedo I., Carlos I. Z., Soares R., Anti-angiogenic effects of pterogynidine alkaloid isolated from Alchornea glandulosa. BMC Complementary and Alternative Medicine 2009 9, article 15 2-s2.0-67651166854 10.1186/1472-6882-9- 15
31. Gorgoulis V. G., Zacharatos P., Kotsinas A., Kletsas D., Mariatos G., Zoumpourlis V., Ryan K. M., Kittas C., Papavassiliou A. G., p53 activates ICAM-1 (CD54) expression in an NF- B-independent manner. EMBO Journal 2003 22 7 1567 1578 2-s2.0-0037388676 10.1093/emboj/cdg157 (Pubitemid 36417405)
32. Vucic D., Franklin M. C., Wallweber H. J. A., Das K., Eckelman B. P., Shin H., Elliott L. O., Kadkhodayan S., Deshayes K., Salvesen G. S., Fairbrother W. J., Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP. Biochemical Journal 2005 385 1 11 20 2-s2.0-19944431887 10.1042/BJ20041108
33. Eckelman B. P., Salvesen G. S., The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. The Journal of Biological Chemistry 2006 281 6 3254 3260 2-s2.0-33645640920 10.1074/jbc.M510863200 (Pubitemid 43845937)
34. Eckelman B. P., Salvesen G. S., Scott F. L., Human inhibitor of apoptosis proteins: Why XIAP is the black sheep of the family. EMBO Reports 2006 7 10 988 994 2-s2.0-33749252583 10.1038/sj.embor.7400795 (Pubitemid 44480512)
35. Li F., Ackermann E. J., Bennett C. F., Rothermel A. L., Plescia J., Tognin S., Villa A., Marchisio P. C., Altieri D. C., Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nature Cell Biology 1999 1 8 461 466 2-s2.0-0033258543 (Pubitemid 129503664)
36. Ren J., Shi M., Liu R., Yang Q. H., Johnson T., Skarnes W. C., Du C., The Birc6 (Bruce) gene regulates p53 and the mitochondrial pathway of apoptosis and is essential for mouse embryonic development. Proceedings of the National Academy of Sciences of the United States of America 2005 102 3 565 570 2-s2.0-14144256097 10.1073/pnas.0408744102 (Pubitemid 40282705)
37. Rothe M., Pan M. G., Henzel W. J., Ayres T. M., Goeddel D. V., The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 1995 83 7 1243 1252 2-s2.0-0029595282 10.1016/0092-8674(95)90149-3 (Pubitemid 26007814)
38. Shu H. D., Takeuchi M., Goeddel D. V., The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proceedings of the National Academy of Sciences of the United States of America 1996 93 24 13973 13978 2-s2.0-0030447483
39. Chu Z. L., McKinsey T. A., Liu L., Gentry J. J., Malim M. H., Ballard D. W., Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF- B control. Proceedings of the National Academy of Sciences of the United States of America 1997 94 19 10057 10062 2-s2.0-0030885421 10.1073/pnas.94.19.10057 (Pubitemid 27406993)
40. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., Bodmer J. L., Schröter M., Burns K., Mattmann C., Rimoldi D., French L. E., Tschopp J., Inhibition of death receptor signals by cellular FLIP. Nature 1997 388 6638 190 195 2-s2.0-0030800070 10.1038/40657 (Pubitemid 27297457)
41. Polsky D., Cordon-Cardo C., Oncogenes in melanoma. Oncogene 2003 22 20 3087 3091 2-s2.0-0038795112 10.1038/sj.onc.1206449 (Pubitemid 36713760)
42. Aggarwal S., Ichikawa H., Takada Y., Sandur S. K., Shishodia S., Aggarwal B. B., Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of I B α kinase and Akt activation. Molecular Pharmacology 2006 69 1 195 206 2-s2.0-30044446136 10.1124/mol.105.017400 (Pubitemid 43048906)
43. Sasi S. P., Yan X., Enderling H., Breaking the "harmony" of TNF-alpha signaling for cancer treatment. Oncogene 2012 31 37 4117 4127
44. Watanabe N., Niitsu Y., Sone H., Therapeutic effect of endogenous tumor necrosis factor on ascites meth a sarcoma. Journal of Immunopharmacology 1986 8 2 271 283 2-s2.0-0022444104 (Pubitemid 16068599)
45. Wang C. Y., Guttridge D. C., Mayo M. W., Baldwin A. S. Jr., NF- b induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Molecular and Cellular Biology 1999 19 9 5923 5929 2-s2.0-0032588317 (Pubitemid 29399297)
46. Sprowl J. A., Reed K., Armstrong S., Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells. Breast Cancer Research 2012 14, article R2
47. Guttridge D. C., Albanese C., Reuther J. Y., Pestell R. G., Baldwin A. S. Jr., NF- B controls cell growth and differentiation through transcriptional regulation of cyclin D1. Molecular and Cellular Biology 1999 19 8 5785 5799 2-s2.0-0032588186 (Pubitemid 29339933)
48. Taira N., Mimoto R., Kurata M., DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells. The Journal of Clinical Investigation 2012 2 3 859 872
49. Hsu Y. L., Kuo P. L., Chiang L. C., Lin C. C., Involvement of p53, nuclear factor b and Fas/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin d in human hepatoma cell lines. Cancer Letters 2004 213 2 213 221 2-s2.0-4344636755 10.1016/j.canlet.2004.03.044 (Pubitemid 39140980)
50. Mognol G. P., de Araujo-Souza P. S., Robbs B. K., Teixeira L. K., Viola J. P., Transcriptional regulation of the c-Myc promoter by NFAT1 involves negative and positive NFAT-responsive elements. Cell Cycle 2012 5 1014 1028
51. Garg A., Aggarwal B. B., Nuclear transcription factor- B as a target for cancer drug development. Leukemia 2002 16 6 1053 1068 2-s2.0-0036275467 10.1038/sj/leu/2402482 (Pubitemid 34618844)
52. Kausar H., Jeyabalan J., Aqil F., Berry anthocyanidins synergistically suppress growth and invasive potential of human non-small-cell lung cancer cells. Cancer Letters 2012 325 1 54 62
53. Chen L. M., Kuo C. H., Lai T. Y., Lin Y. M., Su C. C., Hsu H. H., Tsai F. J., Tsai C. H., Huang C. Y., Tang C. H., RANKL increases migration of human lung cancer cells through intercellular adhesion molecule-1 up-regulation. Journal of Cellular Biochemistry 2011 112 3 933 941 2-s2.0-79951804629 10.1002/jcb.23009
54. Ramer R., Bublitz K., Freimuth N., Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. The FASEB Journal 2012 26 4 1535 1548
55. Gasparini G., Longo R., Sarmiento R., Morabito A., Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? Lancet Oncology 2003 4 10 605 615 2-s2.0-0141963117 10.1016/S1470-2045(03)01220-8 (Pubitemid 37258402)
56. Byrne A. M., Bouchier-Hayes D. J., Harmey J. H., Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF). Journal of Cellular and Molecular Medicine 2005 9 4 777 794 2-s2.0-30944440262 10.1016/S0001-2092(06)60356-6 (Pubitemid 43116546)
57. Song J. W., Munn L. L., Fluid forces control endothelial sprouting. Proceedings of the National Academy of Sciences of the United States of America 2011 108 37 15342 15347
58. Lu X. L., He S. X., Ren M. D., Wang Y. L., Zhang Y. X., Liu E. Q., Chemopreventive effect of saikosaponin-d on diethylinitrosamine-induced hepatocarcinogenesis: involvement of CCAAT/enhancer binding protein beta and cyclooxygenase-2. Molecular Medicine Reports 2012 5 3 637 644
59. Wang Q., Zheng X. L., Yang L., Shi F., Gao L. B., Zhong Y. J., Sun H., He F., Lin Y., Wang X., Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells. Journal of Experimental and Clinical Cancer Research 2010 29 1, article 159 2-s2.0-78649784579 10.1186/1756-9966-29-159
60. Wu G. C., Wu H., Fan L. Y., Pan H. F., Saikosaponins: a potential treatment option for systemic lupus erythematosus. Irish Journal of Medical Science 2011 180 1 259 261 2-s2.0-79954444349 10.1007/s11845-010-0646-4
61. Zheng J. X., Lu K. Q., Xia D. G., Tian G. R., Huang Z. J., Therapeutic effects and mechanism of saikosaponin-d in mice with bleomycin-induced pulmonary fibrosis. Zhonghua Yi Xue Za Zhi 2010 90 12 808 812 2-s2.0-77956396409
62. Wu S. J., Tam K. W., Tsai Y. H., Chang C. C., Chao J. C. J., Curcumin and saikosaponin A inhibit chemical-induced liver inflammation and fibrosis in rats. American Journal of Chinese Medicine 2010 38 1 99 111 2-s2.0-77951219887 10.1142/S0192415X10007695
63. Wohlfarth C., Efferth T., Natural products as promising drug candidates for the treatment of hepatitis B and C. Acta Pharmacologica Sinica 2009 30 1 25 30 2-s2.0-64849111443 10.1038/aps.2008.5
64. Cheng P. W., Ng L. T., Chiang L. C., Lin C. C., Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clinical and Experimental Pharmacology and Physiology 2006 33 7 612 616 2-s2.0-33745171392 10.1111/j.1440-1681.2006.04415.x (Pubitemid 43894022)
65. Li P., Gong Y., Zu N., Li Y., Wang B., Shimizu F., Therapeutic mechanism of Saikosaponin-d in anti-Thy1 mAb 1-22-3-induced rat model of glomerulonephritis. Nephron. Experimental Nephrology 2005 101 4 e111 e118 2-s2.0-33645831595